For example, CCL18 decreases the proliferation of acute lymphocytic leukemia B cells [271] and cutaneous T-cell lymphoma (CTCL) [272] in a process dependent on GPR30 that affects the activity of CXCR4 [271]. Here, CCL18 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.